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A number of cellular processes, as cell proliferation,
apoptosis and cytoskeleton assembly [1], are regulated
by enzymes belonging to the family of histone deacety-
lases (HDACs). Extended or local changes in chromatin
structure are driven by an interplay between histone
acetyltransferases (HATs) and HDACs, and both of
enzymes are involved in post-translational modifications
of histones involving the control of the genes expression
[2]. One of the most studied post-modification is the
acetylation of the lysine residues in the N-terms of the
histone cores mediated by the HDACs enzymes, which
contains four distinct subgroups: CLASS I (HDACs 1, 2,
3 and 8), CLASS II (HDACs 4, 5, 6 and 7), CLASS III
(SIRTUINS) and CLASS IV (HDAC11).
T h ee n z y m eu n d e rs t u d yw a st h eH D A C 7a n dd u et o
the absence of specific inhibitors of this enzyme we
adopt both ligand-based and structure-based approaches
to filter from a 7 million commercial compounds data-
base, an ensemble of molecules to test versus HDAC7.
The starting point of our approach was to collect all
Metal-Binding heads (MTH) and all kind of Linker
between the MTH and the Capping Groups of all avail-
able compounds binding all HDACs, and generate all
possible combinations among all three moieties. All
compounds of this virtual database have been submitted
to a conformational search in which a maximum of 255
conformers have been stored per molecules. This last
3D virtual database has been filtered by a pharmaco-
phore built on the tridimensional structure of the
HDAC7 in complex with TSA (PDB ID: 3C10).
The molecules able to satisfy the pharmacophore have
been submitted to a docking phase to filter molecules
with a high propensity to interact with HDAC7 enzyme.
A panel of 960 compounds have been purchased and
tested on HDAC7 and the most interesting have been
characterized against other HDACs.
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